March 1, 2008

IDSA Advocacy Update
Protecting Infectious Diseases Program Funding, Supporting Pandemic Planning

As Congress debates funding levels for federal infectious diseases programs, IDSA is working to protect infectious diseases programs at the National Institutes of Health and Centers for Disease Control and Prevention as well as to support additional funding in key areas.  IDSA’s efforts are in response to significant funding cuts in President Bush’s proposed budget for fiscal year (FY) 2009.

IDSA’s recent letter to Congress focuses on protecting and strengthening antimicrobial resistance, immunization, HIV/AIDS, pandemic influenza and other key program funding. 

IDSA and the Trust for America’s Health also have urged Congress to significantly increase funding in FY 2009 for the Biomedical Advanced Research and Development Authority (BARDA). BARDA’s mission is to support research and development of critically needed medical countermeasures against biological, chemical, nuclear, and radiological attacks as well as naturally occurring threats such as pandemic influenza.

The Society also signed on to a letter developed by the Working Group on Pandemic Influenza urging Congress to adequately fund pandemic influenza activities in FY 2009.

Other advocacy efforts include:

< Previous Article | Next Article >

ACIP Makes New Recommendations on Flu, MMRV Vaccines
CID Supplement Provides New Insight on Clostridium difficile Infection
EIN Reports Cases of Hyperviscous Klebsiella pneumoniae with Liver Abscesses
IDSA E-mail Alerts: Ricin, Influenza, HIV/AIDS, Other ID Topics
Fluoroquinolone-resistant Meningococcus Reported
In the IDSA Journals
In Wake of Unusual Case, Immunization Experts Seek to Reassure Public about Vaccine Safety
Infection Prevention Brochure Updated
New Toolkit Helps Community Leaders Prepare for Pandemic Influenza
Hib Vaccination Increasing in Low-income Countries
Indonesia Sends WHO First H5N1 Samples in Months
President Announces Initiative to Fight Neglected Tropical Diseases
How to Code for Extra-long Subsequent Hospital Visits
IDSA Advocacy Update
NIAID Resistance Research Agenda, Shortcomings Highlighted in JID
Welcome, New IDSA Members!
Search Back Issues
Forward this Issue
Print-Friendly Version

Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA